Beta Bionics Inc. (BBNX) Stock: Dividends & Earnings

Company Overview:

Market Cap: $0

Trailing PE: N/A

FWD PE: —

Payout Ratio (TTM): —

52-Week Range: $8.80 - $32.71

1.7 Year BBNX Performance Metrics:

Total Return (with DRIP): -19.7% (-12.09% CAGR)

Total Return (no DRIP): -19.7% (-12.09% CAGR)

Share Price: -19.7% (-12.09% CAGR)

Yield on Cost (with DRIP): —

Total Invested: $10,000

Total Value (with DRIP): $8,032

Total Return $ (with DRIP): -$1,968

BBNX Total Return

1M 3M 6M YTD 1Y 3Y 5Y 10Y

BBNX Price Chart

1M 3M 6M YTD 1Y 3Y 5Y 10Y All

Unlock All Reports & Research Dividend Stocks like a BOSS!

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Projected Future Returns & Dividends for BBNX

Based on past 1.7-year performance, here are BBNX growth metrics:

Share price CAGR of -12.09%
Dividend CAGR of +0%

Using BBNX CAGR metrics, we can estimate that your initial $10000 investment, over the next 10 years, should grow as follows:

	BBNX (DRIP)	BBNX - No DRIP
Current Price	$18.98	$18.98
Start Shares	526.87	526.87
Start Value	$10,000	$10,000

After 10 years:
Final Share Count	526.87	526.87
Dividends Payment	$0.00	$0.00
Annual Dividends	$0	$0
Yield on cost	0.00%	0.00%
Share Price	$9.96	$18.98
Total Dividends	$0	$0
Final Value	$5,249	$10,000

Estimated Future Value + Dividends - BBNX

NOTE: Above numbers are our estimate based on BBNX's Dividend and Price CAGR over past 1.7 years. These numbers should only be considered as "potential future returns"! DRIP assumes reinvesting dividends; No-DRIP assumes collecting dividends as cash.

We cannot guarantee that your actual returns will meet these estimates.

Get the best Dividend Stock Research Tools:

Save 25% with annual plan (3 Months Free)

PRO

$171 ($14.25/mo) $102.60/yr ($8.55/mo)

7-day free trial

Unlimited Portfolio Tracker
Portfolio - Lots/Sales/Dividends
Portfolio Auto-DRIP
Buy/Sell Signals Dashboard
Stock Fundamentals
Compare Stocks Side-by-Side
Revenue & EPS Estimates
DCF Valuation Modeling

Try it free for 7 days

You save $125.40 (55%)

Company Info

Beta Bionics Inc. (BBNX) had its IPO on , and is traded on NASDAQ stock exchange.

Beta Bionics Inc. is a commercial-stage medical device company focused on automated insulin delivery for people with insulin-requiring diabetes. Its core product, the iLet Bionic Pancreas, is designed to simplify day-to-day diabetes management by using adaptive closed-loop algorithms to determine insulin dosing. Beta Bionics offers systems and related solutions for adults and children with type 1 diabetes, alongside supporting software and connected tools that help streamline treatment workflows. The company operates in the diabetes technology and medical devices markets, where it addresses the needs of patients, caregivers, and healthcare providers seeking more integrated insulin management solutions. Headquartered in Irvine, California, Beta Bionics plays a role in advancing device-based diabetes care through commercially available products centered on automated insulin delivery.

BBNX website: https://www.betabionics.com